A Double-Blind, Placebo-Controlled Study of Vortioxetine in the Treatment of Binge Eating Disorder
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Vortioxetine (Primary)
- Indications Binge-eating disorder
- Focus Therapeutic Use
- 16 Jun 2016 Planned End Date changed from 1 Oct 2017 to 1 Oct 2018.
- 16 Jun 2016 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2018.
- 16 Jun 2016 Status changed from not yet recruiting to recruiting.